Intra-aortic balloon pump (IABP) therapy fails to reduce infarct size or improve clinical outcomes when added prior to primary percutaneous coronary intervention (PCI) in patients with high-risk ...

Teleflex announced FDA clearance for an intra-aortic balloon pump for the treatment of patients with severe arrhythmias or heart rates up to 200 beats per minute, including those who were originally ...

MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...

A Japanese study of intra-aortic balloon pumps appears to indicate the devices do little to improve outcomes for patients with acute cases and may increase the chances of death. In the registry study ...

Tochigi, Japan - A study comparing the effects of enhanced external counterpulsation (EECP) and intra-aortic balloon pump therapy (IABP) on blood flow in patients post-MI indicates that both methods ...

Getinge is recalling 4,338 intra-aortic balloon pumps after discovering fluid leaks that can lead to unexpected shutdowns or the inability to initiate therapy, the FDA said Dec. 16. The agency has ...

Please provide your email address to receive an email when new articles are posted on . To start, PRODIGY was a very interesting and potentially important study. In PRODIGY, patients receiving a ...

The Global Intra-Aortic Balloon Pump (IABP) market study provides critical information related to the global, regional and top players including Intra-Aortic Balloon Pump (IABP) market share analysis, ...

WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...